Acelrx Pharmaceuticals Inc Működési árrés
Mi az Acelrx Pharmaceuticals Inc Működési árrés?
A Működési árrés az Acelrx Pharmaceuticals Inc - -3,221.70%
Mi a Működési árrés meghatározása?
A működési árrés a működési bevételek aránya a nettó árbevétel és százalékban kifejezve.
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
Működési árrés a Health Care szektor a NASDAQ-on cégekben a Acelrx Pharmaceuticals Inc -hoz képest
Mit csinál Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
működési árrés -hoz hasonló cégek Acelrx Pharmaceuticals Inc
- NightFood nak Működési árrés -3,297.50% van
- ReNu nak Működési árrés -3,285.00% van
- Horizon Gold nak Működési árrés -3,281.25% van
- Electricite et Eaux de Madagascar Societe Anonyme nak Működési árrés -3,258.57% van
- Energous nak Működési árrés -3,244.15% van
- Victory Mines nak Működési árrés -3,232.95% van
- Acelrx Pharmaceuticals Inc nak Működési árrés -3,221.70% van
- Sahara nak Működési árrés -3,211.27% van
- Deinove SA nak Működési árrés -3,207.57% van
- Precigen Inc nak Működési árrés -3,199.18% van
- Magnetic Resources NL nak Működési árrés -3,195.57% van
- CytoTools AG nak Működési árrés -3,190.32% van
- Bold Capital Enterprises nak Működési árrés -3,180.63% van